Clinical Trial Update: Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and tolerability of PCI-27483 in pancreatic cancer patients receiving gemcitabine; the study is completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PCI-27483 (PCI-27483)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Pancreatic Cancer, Ductal Adrenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-04-02